PARIS--(BUSINESS WIRE)--Medical device pioneer Stentys announced today that clinical results from the ‘OPEN I’ clinical study using its bifurcated stent will be presented at next week’s Transcatheter Cardiovascular Therapeutics (‘TCT’) 2008 symposium, an international medical meeting on cardiovascular intervention. The clinical data — to be presented by Stefan Verheye, M.D., Department of Cardiology, Middelheim, Antwerp, Belgium — will look at safety after 30 days post-implantation of the Stentys bifurcated stent in a total of 40 patients.
